Nuvation Bio Inc. Share Price & Technical Analysis
NUVB · $4.72 (-1.46%)
Healthcare / Biotechnology
$4.72
-1.46%
Nuvation Bio Inc., a clinical-stage biopharmaceutical company, focuses on developing product candidates for cancer treatment. The company's lead product candidate is IBTROZI (taletrectinib), a ROS1 inhibitor for the treatment of patients with ROS1+ non-small cell lung cancer. It is also developing Safusidenib, an inhibitor of mutant isocitrate dehydrogenase 1 in phase 3 clinical trials for the mai…
Price chart
Seasonality
May has 2 positive and 2 negative years (last 5 years shown)
7% return in May, 0% avg return in past 3 year May month.
-46% return in 2026, 76% avg return in past 3 years.
Swipe sideways to see all months →
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Yr | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 26 | -42% | 13% | -25% | 0% | 7% | – | – | – | – | – | – | – | -46% |
| 25 | -15% | -13% | -14% | 22% | -5% | -9% | 20% | 30% | 23% | 41% | 51% | 14% | 146% |
| 24 | 7% | 19% | 89% | -19% | 3% | -6% | 27% | -16% | -28% | -4% | 32% | -7% | 96% |
| 23 | 32% | -24% | -11% | -6% | 0% | 13% | 6% | -16% | -19% | -23% | 20% | 15% | -13% |
| 22 | -30% | -18% | 8% | -11% | -26% | -11% | -12% | 4% | -21% | -4% | -14% | 0% | -136% |
Monthly return % by calendar month · historical pattern, not a forecast
Weak · Downtrend · Uptrend
Nuvation Bio Inc., a clinical-stage biopharmaceutical company, focuses on developing product candidates for cancer treatment. The company's lead product candidate is IBTROZI (taletrectinib), a ROS1 inhibitor for the treatment of patients with ROS1+ non-small cell lung cancer. It is also developing Safusidenib, an inhibitor of mutant isocitrate dehydrogenase 1 in phase 3 clinical trials for the maintenance treatment of high-risk or high-grade IDH1-mutant astrocytoma with safusidenib against placebo. The company was founded in 2018 and is headquartered in New York, New York.
Full AI Q&A, portfolio tracking, and live alerts in the app.
Key metrics
Market cap
$1.65B
P/E ratio
—
52W high
$9.75
52W low
$1.57
Volume
39,29,691
Beta
1.52
Related stocks in Healthcare
Merck & Co Inc Cedear (5…
₹32,900
Abbott Laboratories Cede…
₹30,500
Eli Lilly And Company Ce…
₹25,540
Unitedhealth Group Inc C…
₹17,200
₹6,600
Frequently asked questions
- What is Nuvation Bio Inc. share price today?
- Nuvation Bio Inc. (NUVB) last traded around $4.72 on StockPro. Prices refresh every few minutes during market hours.
- What technical signals does NUVB have?
- StockPro monitors breakouts, volume spikes, EMA reversals, and momentum for NUVB. Download the app for real-time alerts.
- How can I analyze Nuvation Bio Inc. stock?
- Use the price chart, seasonality heatmap, key metrics, and AI insight on this page. For portfolio tracking and push alerts, download StockPro on Android or iOS.